Polaryx is preparing to initiate SOTERIA, a Phase 2, open-label, single-arm basket trial designed to evaluate the safety, tolerability, and clinical activity of PLX-200 across four lysosomal storage ...

GameSpot may get a commission from retail offers. March 17, 2026: We checked for new Dress to Impress codes. Dress to Impress is one of the most popular Roblox experiences out there, with more than 7 ...

Our team of savvy editors independently handpicks all recommendations. If you make a purchase through our links, we may earn a commission. Deals and coupons were accurate at the time of publication ...

If you're looking for DTI codes, IGN's got you covered! In this article, you'll find a list of all the active and working Dress to Impress codes in March 2026 that you can redeem for free rewards and ...

What are the latest Blue Protocol Star Resonance codes? To get a head start in the reworked release of Bandai Namco's anime MMORPG, you're going to want to use new Blue Protocol Star Resonance game ...

Protalix BioTherapeutics received a positive CHMP opinion for Elfabrio’s every-four-weeks dosing in stable adult Fabry patients, pending EC approval by March. PLX’s Elfabrio could halve infusion ...

What are the active NBA 2K25 codes? It's another year in the NBA 2K calendar, and as is tradition, there are plenty of freebies to collect. Over the lifetime of each game in the storied basketball ...

Fabry disease is a rare genetic lysosomal storage disorder in which the body lacks sufficient amounts of an enzyme that breaks down fats. The companies requested to approve the dosing regimen of 2 ...

Arduino is being acquired by Qualcomm subject to regulatory approval for an undisclosed sum. Qualcomm Arduino introduces a new UNO form factor board, the Arduino UNO Q, which features both a STM32 MCU ...

You can trust VideoGamer. Our team of gaming experts spend hours testing and reviewing the latest games, to ensure you're reading the most comprehensive guide possible. Rest assured, all imagery and ...

Plexium has raised $60.1 million, providing an infusion of cash for the recently slimmed-down protein degrader specialist three years on from its breakout year. The biotech put itself on the map in ...